Celcuity (CELC) Capital Expenditures (2016 - 2025)
Celcuity (CELC) posted Capital Expenditures of $53000.0 for Q4 2025, down 45.36% on a QoQ basis from $97000.0 in Q3 2025, and up 17.78% year-over-year from $45000.0 in Q4 2024.
Celcuity (CELC) Capital Expenditures (2016 - 2025) Analysis & Trends
Celcuity's Capital Expenditures history runs 10 years deep, the most recent figure standing at $53000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 17.78% year-over-year to $53000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $249000.0 (changed 0.4% YoY) and the FY2025 annual result came in at $249000.0, changed 0.4% from the prior year.
- Capital Expenditures was $53000.0 for Q4 2025 at Celcuity, down from $97000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $112044.0 in Q4 2022 and bottomed at $4854.0 in Q2 2023.
- A 5-year average of $41865.5 and a median of $35849.5 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures slumped 78.88% — and 2024, when it soared 1218.5%.
- Celcuity's Capital Expenditures stood at $9939.0 in 2021, then surged by 1027.32% to $112044.0 in 2022, then sank by 70.82% to $32699.0 in 2023, then jumped by 37.62% to $45000.0 in 2024, then advanced by 17.78% to $53000.0 in 2025.
- Business Quant data shows CELC's Capital Expenditures at $53000.0 in Q4 2025, $97000.0 in Q3 2025, and $39000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 32,699.00 |
| Dec 31, 2023 | 32,699.00 |
| Sep 30, 2023 | 53,104.00 |
| Sep 30, 2023 | 53,104.00 |